TCM product approved for sale in Singapore
Share - WeChat


Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- Jingdezhen a 'rare space' for creators, French ceramic artist says
- China revitalizes 88 key rivers, lakes in ecological restoration drive
- La Nina weather pattern could bring extreme cold, droughts, says NCC
- A march of faith: 74-year-old Hong Kong man retraces the Long March on foot
- Tianjin hosts events highlighting status as international destination
- Chinese startup Interphase takes top prize at Kering Generation Award